findmyKOL

Nihar Desai, MD, MPH

Enriched profile

Associate Professor of Medicine (Cardiovascular Medicine); Vice Chief, Section of Cardiovascular Medicine · Yale School of Medicine

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 New Haven, CT · Northeast · United StatesSpecialtyCardiovascular DiseaseFocusHeart Failure Treatment and Management+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Nihar Desai is Associate Professor of Medicine (Cardiovascular Medicine); Vice Chief, Section of Cardiovascular Medicine at Yale School of Medicine. OpenAlex indexes 531 publications with 16,011 citations (h-index 56); ClinicalTrials.gov lists 3 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.

Data verified 15 Oct 2026

Overview

Updated 15 Oct 2026

Nihar R. Desai, MD, MPH, is Associate Professor of Medicine (Cardiovascular Medicine) at Yale School of Medicine, Section of Cardiovascular Medicine, Department of Internal Medicine. The public record shows 531 publications with 16,011 citations (h-index 56), centered on Heart Failure Treatment and Management, Health Systems, Economic Evaluations, Quality of Life, Lipoproteins and Cardiovascular Health. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 26 companies.

  • Most recent indexed publication: 2026 · Journal of the American Heart Association
  • Top research focus: Heart Failure Treatment and Management
  • 3 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 26 companies

Generated from the cited public record · current as of 15 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Heart Failure2 trialsDyslipidemia / Lipid Disorders

Research focus

OpenAlex concept fingerprint
Heart Failure Treatment and ManagementHealth Systems, Economic Evaluations, Quality of LifeLipoproteins and Cardiovascular HealthMechanical Circulatory Support DevicesAcute Myocardial Infarction Research

Drugs & molecules

across trials, industry payments and publications
Leqviogeneric · InclisiranClinical trials—Industry payments25Publications1Multaqgeneric · DronedaroneClinical trials—Industry payments1Publications1Repathageneric · EvolocumabClinical trials—Industry payments608Publications—Farxigageneric · DapagliflozinClinical trials—Industry payments58Publications—Kerendiageneric · FinerenoneClinical trials—Industry payments30Publications—Jardiancegeneric · EmpagliflozinClinical trials—Industry payments29Publications—Monoferricgeneric · Ferric derisomaltoseClinical trials—Industry payments6Publications—Xareltogeneric · RivaroxabanClinical trials—Industry payments5Publications—Evkeezageneric · EvinacumabClinical trials—Industry payments4Publications—Veltassageneric · PatiromerClinical trials—Industry payments2Publications—Verquvogeneric · VericiguatClinical trials—Industry payments2Publications—Adempasgeneric · RiociguatClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Amgen Inc.Clinical trials—Industry payments683Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments182AstraZeneca Pharmaceuticals LPClinical trials—Industry payments59Bayer HealthCare Pharmaceuticals Inc.Clinical trials—Industry payments31Novartis Pharmaceuticals CorporationClinical trials—Industry payments26Merck Sharp & Dohme LLCClinical trials—Industry payments21Vifor (International) Ltd.Clinical trials—Industry payments9Boehringer Ingelheim International GmbHClinical trials—Industry payments7Eli Lilly and CompanyClinical trials—Industry payments7Pharmacosmos Therapeutics Inc.Clinical trials—Industry payments6Heartflow, Inc.Clinical trials—Industry payments5Vifor Fresenius Medical Care Renal Pharma Ltd.Clinical trials—Industry payments5Vifor Pharma, Inc.Clinical trials—Industry payments5Janssen Pharmaceuticals, IncClinical trials—Industry payments4Regeneron Healthcare Solutions, Inc.Clinical trials—Industry payments4CSL BehringClinical trials—Industry payments3Yale UniversityClinical trials3Industry payments—Lilly USA, LLCClinical trials—Industry payments2Amarin Pharma Inc.Clinical trials—Industry payments1Janssen Scientific Affairs, LLCClinical trials—Industry payments1Novo Nordisk ASClinical trials—Industry payments1Novo Nordisk IncClinical trials—Industry payments1Sanofi Pasteur Inc.Clinical trials—Industry payments1Sanofi-Aventis U.S. LLCClinical trials—Industry payments1Servier Pharmaceuticals LLCClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
531publications

Distinct works indexed by OpenAlex, matched via ORCID; 24 in PubMed.

16,011citations

Total citations across indexed works.

56h-index

Hirsch index (OpenAlex). i10-index 219.

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials ↓
26companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Public positions

sourced statements on record

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 15 Oct 2026

Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 15 Oct 2026

26 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 15 Oct 2026

5 congress contributions (2020–2026) across ADA, ASCO, ASH per OpenAlex. The most recent:

Publications

Updated 15 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 15 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Tariq Ahmad104Harlan M. Krumholz86Joseph S. Ross54Erica S. Spatz53P. Elliott Miller46Jeptha P. Curtis40Frederick A. Masoudi37Fouad Chouairi30Avirup Guha30Michael Fuery30Sanket S. Dhruva28Rohan Khera28Khurram Nasir27John A. Spertus26Katherine Clark25F. Perry Wilson24Salim S. Virani24César Caraballo24Ralph J. Riello23Eric J. Velazquez23Clancy W. Mullan23Javier Valero‐Elizondo23Megan McCullough20Deepak L. Bhatt19Kamil F. Faridi19Samuel W. Reinhardt19Neal G. Ravindra18Karl E. Minges18Craig S. Parzynski17Michael J. Blaha16Ron Blankstein16Marc S. Sabatine16Arnar Geirsson16Sounok Sen16Bobak J. Mortazavi15Yu Yamamoto15Larry A. Allen14James V. Freeman13Karthik Murugiah13Daniel Addison13

Online presence

Updated 15 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • ResearchGate

    researchgate.net/scientific-contributions/Nihar-R-Desai-15620014

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • X / Twitter

    x.com/nihardesai927

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 15 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acc.org ↗
  • Host

    Medscape InDiscussion Cardiorenal Metabolic Syndrome podcast series (Season 1)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medscape.com ↗

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances
  • Video interview series

    "Nihar Desai, MD, MPH: Improving PCSK9 Inhibitor Use, Guiding Heart Failure Care & ACC 2022 Headlines", HCPLive

    2022
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hcplive.com ↗
  • Host

    Medscape InDiscussion: Cardiorenal Metabolic Syndrome podcast series, discussing AHA presidential statement on cardiovascular-kidney-metabolic health

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medscape.com ↗
  • Interview

    "From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care", AJMC

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ajmc.com ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.